Complement factor H polymorphisms, renal phenotypes and age-related macular degeneration: The Blue Mountains Eye Study

Genes and Immunity

Volumn 9, Issue 3, 2008, Pages 231-239

  Xing, C ^a,b   Sivakumaran, T A ^a   Wang, J J ^c   Rochtchina, E ^c   Joshi, T ^a   Smith, W ^d   Mitchell, P ^c   Iyengar, S K ^a,e  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF SYDNEY   (Australia)

^d UNIVERSITY OF NEWCASTLE   (Australia)

^e CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT FACTOR H;

ADULT; AGED; ARTICLE; ATTRIBUTABLE RISK; AUSTRALIA; CAUCASIAN; CORRELATIONAL STUDY; CREATININE CLEARANCE; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENE MUTATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GLOMERULUS FILTRATION RATE; HEMOLYTIC UREMIC SYNDROME; HETEROZYGOSITY; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; PHENOTYPE; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION;

COMPLEMENT FACTOR H; COMPLEMENT PATHWAY, ALTERNATIVE; GENE FREQUENCY; GENETICS, POPULATION; HUMANS; KIDNEY; MACULAR DEGENERATION; MUTATION, MISSENSE; NEW SOUTH WALES; ODDS RATIO; PHENOTYPE;

EID: 42549152932     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2008.10     Document Type: Article

References (65)

1. Alexander JJ, Quigg RJ. The simple design of complement factor H: Looks can be deceiving. Mol Immunol 2007; 44: 123-132.
2. Rodriguez de Cordoba S, Esparza-Gordillo J, Goicoechea de Jorge E, Lopez-Trascasa M, Sanchez-Corral P. The human complement factor H: functional roles, genetic variations and disease associations. Mol Immunol 2004; 41: 355-367.
3. Zipfel PF, Heinen S, Jozsi M, Skerka C. Complement and diseases: defective alternative pathway control results in kidney and eye diseases. Mol Immunol 2006; 43: 97-106.
4. Colville D, Guymer R, Sinclair RA, Savige J. Visual impairment caused by retinal abnormalities in mesangiocapillary (membranoproliferative) glomerulonephritis type II ('dense deposit disease'). Am J Kidney Dis 2003; 42: E2-E5.
5. Duvall-Young J, MacDonald MK, McKechnie NM. Fundus changes in (type II) mesangiocapillary glomerulonephritis simulating drusen: A histopathological report. Br J Ophthalmol 1989; 73: 297-302.
6. Duvall-Young J, Short CD, Raines MF, Gokal R, Lawler W. Fundus changes in mesangiocapillary glomerulonephritis type II: Clinical and fluorescein angiographic findings. Br J Ophthalmol 1989; 73: 900-906.
7. Mullins RF, Aptsiauri N, Hageman GS. Structure and composition of drusen associated with glomerulonephritis: Implications for the role of complement activation in drusen biogenesis. Eye 2001; 15: 390-395.
8. Mullins RF, Russell SR, Anderson DH, Hageman GS, Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposit associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB J 2000; 14: 835-846.
9. Abrera-Abeleda MA, Nishimura C, Smith JL, Sethi S, McRae JL, Murphy BF et al. Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease). J Med Genet 2006; 43: 582-589.
10. Hageman GS, Anderson DH, Johnson LV, Hancox LS, Taiber AJ, Hardisty LI et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci USA 2005; 102: 7227-7232.
11. Pickering MC, de Jorge EG, Martinez-Barricarte R, Recalde S, Garcia-Layana X, Rose KL et al. Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains. J Exp Med 2007, 204: 1249-1256.
12. Saunders RE, Abarrategui-Garrido C, Fremeaux-Bacchi V, Goicoechea de Jorge E, Goodship TH, Lopez Trascasa M et al. The interactive factor H-atypical hemolytic uremic syndrome mutation database and website: Update and integration of membrane cofactor protein and factor I mutations with structural models. Hum Mutat 2007; 28: 222-234.
13. Saunders RE, Goodship TH, Zipfel PF, Perkins SJ. An interactive web database of factor H-associated hemolytic uremic syndrome mutations: insights into the structural consequences of disease-associated mutations. Hum Mutat 2006; 27: 21-30.
14. Ferreira VP, Herbert AP, Hocking HG, Barlow PN, Pangburn MK. Critical role of the C-terminal domains of factor H in regulating complement activation at cell surfaces. J Immunol 2006; 177: 6308-6316.
15. Giannakis E, Jokiranta TS, Male DA, Ranganathan S, Ormsby RJ, Fischetti VA et al. A common site within factor H SCR 7 responsible for binding heparin, C-reactive protein and streptococcal M protein. Eur J Immunol 2003; 33: 962-969.
16. Herbert AP, Uhrin D, Lyon M, Pangburn MK, Barlow PN. Disease-associated sequence variations congregate in a polyanion recognition patch on human factor H revealed in three-dimensional structure. J Biol Chem 2006; 281: 16512-16520.
17. Perkins SJ, Goodship TH. Molecular modelling of the C-terminal domains of factor H of human complement: A correlation between haemolyfic uraemic syndrome and a predicted heparin binding site. J Mol Biol 2002; 316: 217-224.
18. Edwards AO, Ritter III R, Abel KJ, Manning A, Panhuysen C, Farrer LA. Complement factor H polymorphism and age-related macular degeneration. Science 2005; 308: 421-424.
19. Haines JL, Hauser MA, Schmidt S, Scott WK, Olson LM, Gallins P et al Complement factor H variant increases the risk of age-related macular degeneration. Science 2005; 308: 419-421.
20. Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, Haynes C et al. Complement factor polymorphism in age-related macular degeneration. Science 2005; 308: 385-389.
21. Neary JJ, Conlon PJ, Croke D, Dorman A, Keogan M, Zhang FY et al. Linkage of a gene causing familial membranoproliferative glomerulonephritis type III to chromosome 1. J Am Soc Nephrol 2002; 13: 2052-2057.
22. Tsukaguchi H, Yager H, Dawborn J, Jost L, Cohlmia J, Abreu PF et al A locus for adolescent and adult onset familial focal segmental glomerulosclerosis on chromosome 1q25-31. J Am Soc Nephrol 2000; 11: 1674-1680.
23. Fuchshuber A, Jean G, Gribouval O, Gubler MC, Broyer M, Beckmann JS et al. Mapping a gene (SRN1) to chromosome 1q25-q31 in idiopathic nephrotic syndrome confirms a distinct entity of autosomal recessive nephrosis. Hum Mol Genet 1995; 4: 2155-2158.
24. Vollmer M, Jung M, Kuschendorf F, Ruf R, Wienker T, Reis A et al. The gene for human fibronectin glomerulopathy maps to 1q32, in the region of the regulation of complement activation gene cluster. Am J Hum Genet 1998; 63: 1724-1731.
25. Alexander JJ, Wang Y, Chang A, Jacob A, Minto AW, Karmegam M et al Mouse podocyte complement factor H: The functional analog to human complement receptor 1. J Am Soc Nephrol 2007; 18: 1157-1166.
26. Hogasen K, Jansen JH, Mollnes TE, Hovdenes J, Harboe M. Hereditary porcine membranoproliferative glomerulonephritis type II is caused by factor H deficiency. J Clin Invest 1995; 95: 1054-1061.
27. Pickering MC, Cook HT, Warren J, Bygrave AE, Moss J, Walport MJ et al Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H. Nat Genet 2002; 31: 424-428.
28. Liew G, Mitchell P, Wong TY, Iyengar SK, Wang JJ. CKD increases the risk of age-related macular degeneration. J Am Soc Nephrol 2008; 23 [e-pub ahead of print].
29. Fox CS, Yang Q Cupples LA, Guo CY, Larson MG, Leip EP et al. Genomewide linkage analysis to serum creatinine, GFR, and creatinine clearance in a community-based population: The Framingham Heart Study. J Am Soc Nephrol 2004; 15: 2457-2461.
30. Hunt SC, Coon H, Hasstedt SJ, Cawthon RM, Camp NJ, Wu LL et al. Linkage of serum creatinine and glomerular filtration rate to chromosome 2 in UtAh pedigrees. Am J Hypertens 2004; 17: 511-515.
31. Thompson CL, Klein BE, Klein R, Xu Z, Caprioli J, Joshi T et al. Complement factor H and hemicentin-1 in age-related macular degeneration and renal phenotypes. Hum Mol Genet 2007; 16: 2135-2148.
32. International HapMap Consortium. A haplotype map of the human genome. Nature 2005; 437: 1299-1320.
33. Fisher RA. Combining independent tests of significance. Am Statist 1948; 2: 30.
34. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
35. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470.
36. Lin J, Knight EL, Hogan ML, Singh AK. A comparison of prediction equations for estimating glomerular filtration rate in adults without kidney disease. J Am Soc Nephrol 2003; 14: 2573-2580.
37. Poggio ED, Wang X, Greene T, Van Lente F, Hall PM. Performance of the modification of diet in renal disease and Cockcroft-Gault equations in the estimation of GFR in health and in chronic kidney disease. J Am Soc Nephrol 2005; 16: 459-466.
38. Caprioli J, Castelletti F, Bucchioni S, Bettinaglio P, Bresin E, Pianetti G et al. Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: The C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease. Hum Mol Genet 2003; 12: 3385-3395.
39. Neumann HP, Salzmann M, Bohnert-Iwan B, Mannuelian T, Skerka C, Lenk D et al. Haemolytic uraemic syndrome and mutations of the factor H gene: A registry-based study of German speaking countries. J Med Genet 2003; 40: 676-681.
40. Baird PN, Islam FM, Richardson AJ, Cain M, Hunt N, Guymer R. Analysis of the Y402H variant of the complement factor H gene in age-related macular degeneration. Invest Ophthalmol Vis Sci 2006; 47: 4194-4198.
41. Despriet DD, Klaver CC, Witteman JC, Bergen AA, Kardys I, de Maat MP et al. Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration. JAMA 2006; 296: 301-309.
42. Fisher SA, Rivera A, Fritsche LG, Babadjanova G, Petrov S, Weber BH. Assessment of the contribution of CFH and chromosome 10q26 AMD susceptibility loci in a Russian population isolate. Br J Ophthalmol 2007; 91: 576-578.
43. Magnusson KP, Duan S, Sigurdsson H, Petursson H, Yang Z, Zhao Y et al CFH Y402H confers similar risk of soft drusen and both forms of advanced AMD. PLoS Med 2006; 3: E5.
44. Conley YP, Jakobsdottir J, Mah T, Weeks DE, Klein R, Kuller L et al CFH, ELOVL4, PLEKHA1 and LOC387715 genes and susceptibility to age-related maculopathy: AREDS and CHS cohorts and meta-analyses. Hum Mol Genet 2006; 15: 3206-3218.
45. Schaumberg DA, Christen WG, Kozlowski P, Miller DT, Ridker PM, Zee RY. A prospective assessment of the Y402H variant in complement factor H, genetic variants in C-reactive protein, and risk of age-related macular degeneration. Invest Ophthalmol Vis Sci 2006; 47: 2336-2340.
46. Levin ML. The occurrence of lung cancer in man. Acta Unio Int Contra Cancrum 1953; 9: 531-541.
47. Rockhill B, Newman B, Weinberg C. Use and misuse of population attributable fractions. Am J Public Health 1998; 88: 15-19.
48. Chamberlain M, Baird P, Dirani M, Guyiner R. Unraveling a complex genetic disease: Age-related macular degeneration. Surv Ophthalmol 2006; 51: 576-586.
49. Dewan A, Liu M, Hartman S, Zhang SS, Liu DT, Zhao C et al. HTRA1 promoter polymorphism in wet age-related macular degeneration. Science 2006; 314: 989-992.
50. Gold B, Merriam JE, Zernant J, Hancox. LS, Thiber AJ, Gehrs K et al Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat Genet 2006; 38: 458-462.
51. Hughes AE, Orr N, Esfandiary H, Diaz-Torres M, Goodship T, Chakravarthy U. A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration. Nat Genet 2006; 38: 1173-1177.
52. Li M, Atmaca-Sonmez P, Othman M, Branham KE, Khanna R, Wade MS et al CFH haplotypes without the Y402H coding variant show strong association with susceptibility to age-related macular degeneration. Nat Genet 2006; 38: 1049-1054.
53. Maller J, George S, Purcell S, Fagerness J, Altshuler D, Daly MJ et al. Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration. Nat Genet 2006; 38: 1055-1059.
54. Maller JB, Fagerness JA, Reynolds RC, Neale BM, Daly MJ, Seddon JM. Variation in complement factor 3 is associated with risk of age-related macular degeneration. Nat Genet 2007; 39: 1200-1201.
55. Yang Z, Camp NJ, Sun H, Tong Z, Gibbs D, Cameron DJ et al. A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration. Science 2006; 314: 992-993.
56. Mitchell P, Smith W, Attebo K, Wang JJ. Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study. Ophthalmology 1995; 102: 1450-1460.
57. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW et al. National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Ann Intern Med 2003; 139: 137-147.
58. Klein R, Davis MD, Magli YL, Segal P, Klein BE, Hubbard L. The Wisconsin age-related maculopathy grading system. Ophthalmology 1991; 98 1128-1134.
59. Bird AC, Bressler NM, Bressler SB, Chisholm IH, Coscas G, Davis MD et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol 1995; 39: 367-374.
60. Liang KY, Zeger SL. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986; 42: 121-130.
61. McPeek MS, Wu X, Ober C. Best linear unbiased allele-frequency estimation in complex pedigrees. Biometrics 2004; 60: 359-367.
62. SAS Institute. SAS Guide for Personal Computers: Version 9.1.3. SAS Institute: Cary, NC, 2006.
63. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21 263-265.
64. Browning SR, Briley JD, Briley LP, Chandra G, Charnecki JH, Ehm MG et al. Case-control single-marker and haplotypic association analysis of pedigree data. Genet Epidemiol 2005; 28: 110-122.
65. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 2002; 70: 425-434.